Skip to main content
SupplementScience

Benefits of Spirulina

Reviewed by·PharmD, BCPS

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Cholesterol reduction — a 2016 meta-analysis by Huang et al. of 12 RCTs found spirulina supplementation significantly reduced LDL cholesterol by approximately 16% and triglycerides by 10%, while modestly increasing HDL cholesterol
  • Potent antioxidant — phycocyanin, spirulina's signature blue pigment, scavenges reactive oxygen species and selectively inhibits COX-2 (but not COX-1), providing anti-inflammatory effects without gastric side effects (Romay et al., 2003)
  • Immune modulation — Selmi et al. (2011) demonstrated that spirulina enhances NK cell activity and increases IFN-gamma production, improving innate immune surveillance against viral infections and abnormal cells
  • Allergic rhinitis relief — Cingi et al. (2008) showed 2g/day spirulina significantly reduced nasal congestion, sneezing, nasal discharge, and itching scores compared to placebo in a double-blind RCT of allergic rhinitis patients
  • Blood sugar support — Ou et al. (2013) found spirulina supplementation reduced fasting blood glucose and HbA1c in type 2 diabetic patients, suggesting complementary glycemic benefits

What the Research Says

Spirulina has a moderate evidence base, anchored by several meta-analyses and systematic reviews. Huang et al. (2016) pooled 12 RCTs and found consistent LDL cholesterol reductions (~16%) and triglyceride improvements. Phycocyanin, the primary bioactive compound, has been extensively studied for its selective COX-2 inhibition and antioxidant properties (Romay et al., 2003). Immune modulation research by Selmi et al. (2011) demonstrated enhanced NK cell activity and cytokine production. For allergic rhinitis, Cingi et al. (2008) published a well-designed double-blind RCT showing significant symptom reduction at 2g/day. Blood sugar effects have been explored in smaller trials (Ou et al., 2013) with promising but preliminary results in type 2 diabetes. The main limitations are relatively small sample sizes across trials and heterogeneity in spirulina preparations. Most research uses Arthrospira platensis strains, and contamination remains a quality concern for non-certified products.

References

  1. Huang H, Liao D, Pu R, Cui Y (2018). Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure. Diabetes, Metabolic Syndrome and Obesity. DOI PubMed
  2. Romay Ch, González R, Ledón N, Remirez D, Rimbau V (2003). C-phycocyanin: a biliprotein with antioxidative, anti-inflammatory and neuroprotective effects. Current Protein & Peptide Science. DOI PubMed
  3. Selmi C, Leung PS, Fischer L, German B, Yang CY, Kenny TP, Cysewski GR, Gershwin ME (2011). The effects of Spirulina on anemia and immune function in senior citizens. Cellular & Molecular Immunology. DOI PubMed
  4. Cingi C, Conk-Dalay M, Cakli H, Bal C (2008). The effects of spirulina on allergic rhinitis. European Archives of Oto-Rhino-Laryngology. DOI PubMed
  5. Ou Y, Lin L, Yang X, Pan Q, Cheng X (2013). Antidiabetic potential of phycocyanin: effects on KKAy mice. Pharmaceutical Biology. DOI PubMed
  6. Finamore A, Palmery M, Bensehaila S, Peluso I (2017). Antioxidant, immunomodulating, and microbial-modulating activities of the sustainable and ecofriendly spirulina. Oxidative Medicine and Cellular Longevity. DOI PubMed
  7. Mazokopakis EE, Papadomanolaki MG, Fousteris AA, Kotsiris DA, Lampadakis IM, Ganotakis ES (2014). The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease. Turkish Journal of Gastroenterology. PubMed